Innovative MicroGlucagon solution aims to transform insulin therapy for type 1 diabetics

Researchers in Trondheim are developing a new medicine for diabetics who have to have daily injections of insulin. The key is a hormone that causes the smallest blood vessels to relax on the inside.

Related Keywords

Canada ,Norway ,Norwegian ,Norwegians ,Hilde Kjeldstad Berg ,Sven Magnus Carlsen ,Norwegian University Of Science ,World Health Organization ,Centre For Digital Life Norway ,Norwegian Institute Of Public Health ,Research Council Of Norway ,Norwegian University ,Artificial Pancreas Trondheim ,Olavs Hospital ,Sven Magnus ,Norwegian Institute ,Public Health ,Pancreas Trondheim ,Research Council ,Digital Life ,Intraperitoneal Artificial Pancreas ,Diabetes ,Insulin ,Type 1 Diabetes ,Flood ,Blood Sugar ,Blood Vessels ,Children ,Diabetes Mellitus ,Glucagon ,Glucose ,Ormone ,Hospital ,Medicine ,Pancreas ,Research ,Technology ,